These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 6917564)

  • 1. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogenic peptide substrate assays for determining components of the plasma kallikrein system.
    Gallimore MJ
    Scand J Clin Lab Invest Suppl; 1985; 178():127-32. PubMed ID: 3867113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material.
    Egberg N; Gallimore MJ
    Adv Exp Med Biol; 1983; 156 (Pt B)():1109-17. PubMed ID: 6552857
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromogenic substrate assays for studying components of the plasma kallikrein system in health and disease.
    Gallimore MJ
    Adv Exp Med Biol; 1983; 156():225-31. PubMed ID: 6552839
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
    Roeise O; Bouma BN; Stadaas JO; Aasen AO
    Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.
    Kluft C
    J Lab Clin Med; 1978 Jan; 91(1):83-95. PubMed ID: 618993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bradykinin-forming cascade and its role in hereditary angioedema.
    Kaplan AP; Joseph K
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prekallikrein activation in the adult respiratory distress syndrome.
    Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
    Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
    Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contact system in human malignant and benign ascites.
    Buø L; Karlsrud TS; Johansen HT; Aasen AO
    Scand J Clin Lab Invest; 1993 Apr; 53(2):117-24. PubMed ID: 7682333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
    Dors DM; Nuijens JH; Huijbregts CC; Hack CE
    Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.
    Schapira M; Ramus MA; Waeber B; Brunner HR; Jallat S; Carvallo D; Roitsch C; Courtney M
    J Clin Invest; 1987 Aug; 80(2):582-5. PubMed ID: 3497179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prekallikrein activation and kallikrein inactivation in human plasma.
    van der Graaf F; Keus JF; Koedam JA; Rietveld A; Bouma BN
    Adv Exp Med Biol; 1983; 156():143-8. PubMed ID: 6190365
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromogenic peptide substrate assays in patients with multiple trauma.
    Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
    Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the activation and inhibition of the plasma kallikrein-kinin system.
    Kaplan AP; Reddigari S; Brunnée T; Nishikawa K; Kuna P; Silverberg M
    Agents Actions Suppl; 1992; 38 ( Pt 3)():317-28. PubMed ID: 1462866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.